IGC Pharma
5 hedge funds and large institutions have $10K invested in IGC Pharma in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
73% less capital invested
Capital invested by funds: $37K → $10K (-$27K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$1.62K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$135 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.18K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 4 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
-$1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$49 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $8K | -$6.18K | -11,419 | -38% |
|
|
LTFS
2
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
3
AllianceBernstein
Nashville,
Tennessee
| $1K | +$1.62K | +3,000 | New |
|
|
VKH
4
Virtu KCG Holdings
New York
| – | -$9K | -14,015 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$5K | -7,048 | Closed |
|
|
VIA
6
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$1K | -1,000 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$49 | -91 | -68% |
|
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$135 | +250 | New |
|
IGC Hedge Fund Activity: Q1 2015 in Review
5 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2015, worth a combined $10K — down 73% from $37K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of IGC and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was AllianceBernstein, opening a new position worth an estimated $1.62K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $9K sold.
- 5 institutional investors held IGC Pharma (IGC) as of Q1 2015, down from 6 in Q4 2014.
- Funds reported $10K of IGC Pharma stock for Q1 2015, down 73% quarter-over-quarter.
- 2 funds opened new IGC Pharma positions in Q1 2015 and 3 closed out, a net change of -1 holder.
- The largest IGC Pharma buyer in Q1 2015 was AllianceBernstein, an estimated $1.62K added.
- The largest IGC Pharma seller in Q1 2015 was Virtu KCG Holdings, an estimated $9K sold.
Based on aggregated 13F filings for Q1 2015.